Literature DB >> 12401096

Rotational isomers of N-alkylpyridylporphyrins and their metal complexes. HPLC separation, (1)H NMR and X-ray structural characterization, electrochemistry, and catalysis of O(2)(.-) disproportionation.

Ivan Spasojević1, Ramil Menzeleev, Peter S White, Irwin Fridovich.   

Abstract

Rotational (atropo-) isomers of Mn(III) meso-tetrakis(N-alkylpyridinium-2-yl)porphyrins and corresponding metal-free porphyrin ligands (where alkyl is methyl, ethyl, n-butyl, n-hexyl) and Zn(II) meso-tetrakis(N-methyl(ethyl,n-hexyl)pyridinium-2-yl)porphyrins were separated and isolated by reverse-phase HPLC. The identity of the rotational isomers of metal-free meso-tetrakis(N-methylpyridinium-2-yl)porphyrin was established by (1)H NMR spectra and by the crystal structure of the fastest eluting fraction (R(f) = 7.7%, R(w) = 9.2%, P2(1)/c, Z = 8, a = 14.2846(15) A, b = 22.2158(24) A, c = 29.369(3) A, beta = 95.374(2) degrees ) which, in accordance with (1)H NMR interpretation, proved to be the alphabetaalphabeta isomer. This result, together with elution intensity patterns, was used to identify the fractions of other Mn(III)-porphyrins, Zn(II)-porphyrins, and corresponding metal-free ligands in the series. All of the atropoisomers were inert toward isomerization which was not observable for 30 days at room temperature and reached only 50% in 16 days at 90 degrees C in the case of the Mn(III)-ethyl analogue. However, a complete freeze-dry removal of the mobile phase from the HPLC fractions caused an almost 100% isomerization. The Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, as a mixture of atropoisomers (AEOL-10113), has been shown to offer protection in oxidative stress injury ascribed to its high reactivity toward superoxide (k(cat) = 5.8 x 10(7) M(-1) s(-1)) as a consequence of its favorable redox potential (E(1/2) = +228 mV vs NHE). In this work, the atropoisomers were found to have similar redox potentials ranging from +240 to +220 mV, to be similarly potent catalysts of O(2)(.-) disproportionation (dismutation), with k(cat) ranging from 5.5 x 10(7) to 6.8 x 10(7) M(-1) s(-1), and not to preferentially bind to biological tissue.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401096     DOI: 10.1021/ic025556x

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  14 in total

Review 1.  A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Ludmil Benov
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

2.  Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.

Authors:  T Celic; J Španjol; M Bobinac; A Tovmasyan; I Vukelic; J S Reboucas; I Batinic-Haberle; D Bobinac
Journal:  Free Radic Res       Date:  2014-10-10

Review 3.  Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Artak Tovmasyan; Julio S Reboucas; Xiaodong Ye; Kam W Leong; Mark W Dewhirst; Zeljko Vujaskovic; Ludmil Benov; Ivan Spasojevic
Journal:  Free Radic Biol Med       Date:  2011-05-06       Impact factor: 7.376

4.  Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5+, targets mouse heart mitochondria.

Authors:  Ivan Spasojević; Yumin Chen; Teresa J Noel; Yiqun Yu; Marsha P Cole; Lichun Zhang; Yunfeng Zhao; Daret K St Clair; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2007-01-13       Impact factor: 7.376

5.  Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate.

Authors:  Artak Tovmasyan; Jacqueline C Bueno-Janice; Melba C Jaramillo; Romulo S Sampaio; Julio S Reboucas; Natalia Kyui; Ludmil Benov; Brian Deng; Ting-Ting Huang; Margaret E Tome; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Antioxid Redox Signal       Date:  2018-03-27       Impact factor: 8.401

6.  Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+.

Authors:  Tin Weitner; Ivan Kos; Huaxin Sheng; Artak Tovmasyan; Julio S Reboucas; Ping Fan; David S Warner; Zeljko Vujaskovic; Ines Batinic-Haberle; Ivan Spasojevic
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

7.  Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-alkylpyridylporphyrins.

Authors:  Rima Ezzeddine; Anwar Al-Banaw; Artak Tovmasyan; James D Craik; Ines Batinic-Haberle; Ludmil T Benov
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

8.  Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.

Authors:  Júlio S Rebouças; Gilson DeFreitas-Silva; Ivan Spasojević; Ynara M Idemori; Ludmil Benov; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2008-05-05       Impact factor: 7.376

Review 9.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

10.  Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5+), in plasma and major organs of B6C3F1 mice.

Authors:  Ivan Spasojević; Yumin Chen; Teresa J Noel; Ping Fan; Lichun Zhang; Julio S Rebouças; Daret K St Clair; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2008-05-28       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.